0001611687-24-000002.txt : 20241009 0001611687-24-000002.hdr.sgml : 20241009 20241009105954 ACCESSION NUMBER: 0001611687-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241009 DATE AS OF CHANGE: 20241009 EFFECTIVENESS DATE: 20241009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TearSolutions, Inc. CENTRAL INDEX KEY: 0001611687 ORGANIZATION NAME: IRS NUMBER: 811764681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526266 FILM NUMBER: 241361827 BUSINESS ADDRESS: STREET 1: 315 OLD IVY WAY STREET 2: SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 BUSINESS PHONE: 434-951-0444 MAIL ADDRESS: STREET 1: 315 OLD IVY WAY STREET 2: SUITE 301 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22903 FORMER COMPANY: FORMER CONFORMED NAME: TearSolutions, LLC DATE OF NAME CHANGE: 20140624 D 1 primary_doc.xml X0708 D LIVE 0001611687 TearSolutions, Inc. 315 OLD IVY WAY SUITE 301 CHARLOTTESVILLE VA VIRGINIA 22903 434-951-0444 DELAWARE TearSolutions, LLC Corporation true Gordon W Laurie 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Mark B Logan 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Colin M Rolph 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Anil Asrani 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Director Jens Biertumpel 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director James M Ramey 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Robert J Dempsey 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Executive Officer Director Louis M Alpern 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Amir Shojaei 315 Old Ivy Way, Suite 301 Charlottesville VA VIRGINIA 22903 Director Biotechnology Decline to Disclose 06b false 2024-09-25 false true true true false 0 14025198 12709989 1315209 Equity Shares: $2,260,059 FOR CASH; $8,635,199 issued on conversion of outstanding notes; $390,000 issued in satisfaction of Simple Agreements for Future Equity; plus $1,424,731 for equity shares issuable upon future exercise of warrants false 80 0 0 0 false TearSolutions, Inc. /s/ Colin Rolph Colin Rolph Chief Financial Officer 2024-10-07